ChargePoint Technology unveils new subsidiary in India

Published On 2024-07-07 03:30 GMT   |   Update On 2024-07-07 03:31 GMT

ChargePoint Technology has launched a new subsidiary, ChargePoint UK Private Ltd to expand its presence in India. The subsidiary will focus on business development and providing services tailored to the Company's Indian customers and the broader market.

ChargePoint has recruited six team members for business development, technical service, and aftercare. 

Suresh Chandra has been appointed as Commercial Manager. Manish Chitroda and Pradeep Puduru will join as sales manager across West and South India.

Advertisement

Whereas, Sai Srinivas and Vinayak Bhat join as Field Technical Support Engineers. Gahana Kengeri Jayakumar appointed as AfterCare Support Executive.

Commenting on the firm’s global expansion, our Chris Eccles, said, “The Indian pharmaceutical industry ranks third globally in terms of production by volume and is expected to be valued at $130 billion by 2030.

We’ve been operating in India for over 15 years and have already achieved significant success with our AseptiSafe bio and other containment solutions. As a result, it has been imperative to set up local operations in the region to provide round-the-clock support for our customers. With demand for pharmaceutical manufacturing rapidly increasing in this territory, this has made India a crucial market for our future growth opportunities.”

Advertisement

ChargePoint Technology is a global company with a focus to support and advance the pharmaceutical manufacturing industry, 

Read also: Shilpa Medicare CDMO customer reports positive results from Oxylanthanum Carbonate trial

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News